Acomhal Research Inc. is a biotech startup company spun out of the Fralin Biomedical Research Institute at Virginia Tech Carilion by Drs. Samy Lamouille and Rob Gourdie. Acomhal Research’s mission is to provide novel and effective therapeutic approaches targeting tumor recurrence and metastasis. We are developing new proprietary drugs to more effectively treat primary cancer tumors resulting in less recurrence and fewer metastases, thereby improving patient outcomes.